Commission to push 'buy European' in new critical medicines act
ADVERTISEMENT
The EU executive included a new 'Buy Europe' mechanism with its long-awaited proposal for a Critical Medicines Act, unveiled on Tuesday, a key piece of health legislation for this term. The proposal came just in time to meet Health Commissioner Olivér Várhelyi's self-imposed deadline of 100 days in office.
This accelerated timeline for the proposal has sparked controversy due to the lack of a comprehensive impact assessment and limited stakeholder feedback, but the Commission said the proposal was urgently needed in view of ongoing medicine shortages.
The Act aims to secure stable and reliable supply chains within the EU, ensuring a high level of public health protection and security.
'The Critical Medicines Act ensures that EU patients have access to the medicines they need, when and where they need them at an affordable price. In the current geopolitical context this has become an even bigger priority,' said Várhelyi.
The proposal establishes the security of supply and availability of critical medicines as a strategic EU objective. Achieving this requires a coordinated approach at both national and European levels, the Commission acknowledged.
The Act primarily targets critical medicines included in the EU's list of critical medicinal products drafted by the European Medicines Agency (EMA) in 2023, focusing on drugs used to treat serious conditions or those with limited alternatives.
What's the issue about
The proposal seeks to tackle severe medicine shortages in the EU, particularly for essential drugs such as antibiotics, insulin, and painkillers. Many of these medicines have become difficult to obtain due to reliance on a limited number of manufacturers or countries.
The Commission acknowledges the EU's heavy dependence on foreign suppliers for active pharmaceutical ingredients (APIs) and the risks posed by export disruptions. The COVID-19 pandemic exposed these vulnerabilities, underscoring the need for a more resilient supply chain.
While pharmaceutical companies are responsible for ensuring sufficient medicine supply, individual EU member states oversee distribution within their territories. Most shortages are currently managed at the national level.
'Buy European' is the solution
The new proposal aims to boost investment in manufacturing essential medicines and key ingredients within the EU, reducing external dependencies.
A key measure is a sort of 'Buy European' principle, which introduces public procurement award criteria that prioritise the security of supply over price alone.
In practice, when a vulnerability in supply chains and dependence on a single third country is identified, EU contracting authorities will, where justified, apply procurement requirements favouring suppliers that manufacture a significant portion of these critical medicines within the EU.
These measures will be implemented in compliance with the Union's international commitments. 'This is about increasing EU production capacity and diversifying supply chains to make them more resilient, while also leveraging demand,' an EU official explained.
"The Act will have a positive impact on EU's competitiveness by fostering a more stable and predictable market environment," said Commissioner Olivér Várhelyi in Strasbourg.
European Union - Valentine Zeler
A joint procurement scheme?
The proposal also introduces a novelty, a category of medicines under close review: medicines of common interest. These include medicines with little availability and accessibility in at least three EU member states, such as are used for treatments for rare diseases.
For these medicines, the Commission proposes coordinated procurement mechanisms with member states to prevent inequalities and supply gaps.
ADVERTISEMENT
This could be seen as an attempt to put into practice a much-awaited joint procurement of medicines at the EU level, with the involvement of the European Commission supporting member states in the use of different collaborative procurement tools for critical medicines and other medicines of common interest.
Additionally, the proposal introduces the concept of strategic projects, aimed at bolstering the EU's capacity to manufacture and develop critical medicines.
These projects, located within the EU, will benefit from incentives such as fast-tracked permitting, streamlined environmental assessments, administrative and scientific support and potential EU funding.
Lack of ambition (and money)
Commenting on the proposal, Luxembourgish Green MEP Tilly Metz called for bolder initiatives to reshore medicine production in Europe. 'Joint procurement and just accelerating the processes is not enough,' she told Euronews.
ADVERTISEMENT
Meanwhile, Romanian liberal MEP Vlad Voiculescu welcomed the proposal as a positive step toward greater access to affordable medicines.
'It's a beginning. We hope to see it backed by funding, budgets, and national legislation as soon as possible,' Voiculescu told Euronews.
Concerns remain over financing. Others fear that the proposal's indicative budget of €83 million for 2026-2027, primarily through the EU4Health program, will be insufficient.
Ahead of the proposal's presentation, 11 EU health ministers advocated expanding the scope of the upcoming EU defence funding scheme to include critical medicines. Belgian Health Minister Frank Vandenbroucke, one of the signatories, urged the Commission to integrate the Act into Europe's security and defence framework.
ADVERTISEMENT
'Medicine security is just as important as defence or energy security. Our collective safety depends on it,' he pointed out.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
an hour ago
- Euronews
Researchers develop new bracelet that can detect the date rape drug
One in three adult women across the EU have experienced sexual or physical assault, according to the European Union Agency for Fundamental Rights. This includes what is known as drug-facilitated sexual assault (DFSA). Faced with these alarming statistics, a team of chemists from Portugal and Spain, led by Carlos Lodeiro Espiño of Universidade NOVA de Lisboa, has presented a prototype of a paper bracelet equipped with a chemical sensor. At first glance, it looks like an ordinary festival wristband. In reality, it is a microscopic laboratory of its own, one that can detect the presence of the date rape drug Gamma-hydroxybutyrate, otherwise known as GHB, as well as other intoxicating substances, within a matter of seconds. The invention, which could hit European festivals and clubs as early as this year, has the potential to significantly reduce the number of sexual assaults. How does the wristband work? The lightweight and biodegradable bracelet conceals two miniature colourimetric sensors, one of which reacts to the presence of GHB. Simply wet a section of the band with a drop of drink. If it turns green, that indicates the presence of an unwanted substance. The entire chemical reaction takes a few seconds and the result is visible to the naked eye. "It's a product designed as a personal shield. It can work for up to five days, repeatedly testing different drinks," explains Professor Carlos Lodeiro Espiño, who led the research into the bracelet. Why is GHB so dangerous? GHB is colourless, odourless and metabolises quickly in the body. Just a few hours after ingestion, it can be virtually undetectable in standard tests. Victims often lose consciousness or memory of events, making subsequent investigation difficult. In Europe, up to a third of sexual assaults involving chemical agents take place precisely after the administration of GHB or its derivatives. From the laboratory to the club The project is a collaboration between researchers from Portugal and the University of Valencia in Spain. The research into the sensors took several months, building on 20 years of experience in optical detection methods. The first batches of bracelets have already made their way to concerts, festivals and popular clubs in Spain and Portugal. During the summer, when tourist traffic is at its highest and partying continues until dawn, the risk of drinks being spiked increases significantly. If the project gains enough traction, its creators plan to expand distribution to more European countries. "This armband will not solve the problem of sexual violence, but it can play an important role in its prevention," the researchers emphasise. Price and availability The cost of a wristband is expected to be between €3 and €5. Additionally, packaged versions containing multiple bracelets will bring the cost of daily protection down to less than €1. However, the creators hope that funding will be provided by event organisers, local authorities and public institutions - as part of "safe festival" programmes. Other tests are available The wristbands are just one option, as there are other technological and chemical solutions that work. For instance, disposable test strips that can be dipped into a drink are on sale and indicate the presence of certain drugs. Also popular are discreet stickers that change colour when they come into contact with a beverage. A team of researchers in South Korea has developed a temporary tattoo, the design of which will instantly change colour from yellow to red when in contact with a "rape pill". Elsewhere, students in the department of materials engineering at North Carolina State University have developed a nail polish that changes colour upon contact with substances that render a person vulnerable to sexual assault. Not just a test - a deterrent Although the results obtained from the bracelet are not currently treated as evidence in court, the mere fact of having it can be a deterrent to potential perpetrators. In the Valencia region, following the introduction of the wristbands, the number of reports of attempted intoxication at festivals dropped to almost zero. Researchers are already working on a second generation of the device, which would gain formal recognition from law enforcement agencies across Europe.
Euronews
2 hours ago
- Euronews
Hunting microplastics: French scientists sound the alarm on plastic pollution
The Mediterranean is the sixth largest accumulation zone for marine litter. It holds only 1% of the world's waters but concentrates 7% of all global microplastics. This is why French scientists from the Exploration Bleue project have come off the coast of Toulon to study the impact of microplastic pollution in the Mediterranean Sea. Their expeditions are led by the NGO Expédition 7ᵉ Continent's 27-metre sailing vessel. 'The Mediterranean is an enclosed sea with a dense population. All human activity ends up in the sea. We study the chemical pollutants carried by plastics. What we already know is that all of them contain chemical pollution,' explains Alexandra Ter-Halle, Director of Research at the French National Centre for Scientific Research (CNRS) and scientific coordinator of the expedition. The research involves towing two trawls for one hour to collect microplastic samples. These will then be sorted in the laboratories participating in the project. Alexandra has been studying the chemical nature of pollutants associated with plastics for years at the University of Toulouse. 'We measure and weigh microplastics; we analyse their composition. We know that over 16,000 chemical substances are used to make plastics — 4,000 of them are already classified as hazardous.' When marine animals are exposed to microplastics, chemical substances can transfer into their bodies. Since many of these are endocrine disruptors, they impact the animals' health. The effects on humans are not yet fully understood, as Alexandra explains: 'We know that endocrine disruptors affect the entire hormonal system in our bodies. They impact fertility and the development of cancer, but we still have many questions about this plastic pollution.' Science is only just beginning to understand how dangerous microplastics can be for ecosystems and human health. We eat, breathe and drink them — but there's still much we don't know. For micro- and nanoplastics, which are often smaller than a thousandth of a millimetre, we lack precise tools to measure them or fully grasp their effects, scientists say. The European Commission's Zero Pollution Action Plan aims to cut microplastics by 30% by 2030. Jean-François Ghiglione, a marine microbiologist and research director at CNRS, led an unprecedented sampling campaign across nine major European rivers in 2019. He found microplastics everywhere in 'alarming' concentrations. 'Europe is quite advanced in this area,' explains Ghiglione. 'We used to have massive plastic pollution, mainly from packaging and single-use plastics. That was the European Union's initial target. Now, we're hoping to see a shift in how plastic is perceived.' So far, plastic has been viewed as waste, and efforts have focused on waste management. Ghiglione hopes the EU will drive a push for a drastic reduction in plastic production, and also come out with a list of chemical substances to be banned from use in plastics. Europe has made progress in limiting microplastics, but Ghiglione and the scientific community are calling for more. With negotiations for a global treaty still underway, Europe and the international community face a choice: continue managing pollution, or tackle the problem at its root.
Euronews
3 hours ago
- Euronews
Zelenskyy and European leaders speak with Trump ahead of Putin meeting
As Donald Trump is about to meet one-on-one with Vladimir Putin on Friday, Ukraine's president together with the European leaders is trying to convince his US counterpart that the future of Russia's all-out war against Ukraine cannot be discussed without Kyiv in the room. Volodymyr Zelenskyy has come to Berlin on Wednesday to join German Chancellor Merz for video calls in a last-minute bid to ensure the US president understands what is at stake for Ukraine and the continent. Although Trump stated that his ultimate goal is to bring Zelenskyy and Putin to the negotiating table, this will not happen in two days' time, when the US and Russian leaders are to meet in Alaska. Ukraine's president is not scheduled to participate in the Alaska summit, nor are the European leaders. Follow our live blog below as our journalists from across Europe bring you the latest developments in today's top story.
